A PYMNTS Company

US: Actavis’s $25B buy could offer big payday to Forest Labs founder

By  |  May 5, 2014

The head of Forest Laboratories, Howard Solomon, is reportedly slated to make $100 million or more from his company’s $25 billion merger with pharmaceutical giant Actavis, according to reports.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Reports say documents recently filed with the US Securities and Exchange Commission suggest Actavis is preparing to acquire Forest, a notice that hints at corporate restructuring at the firm.

    According to reports, Solomon stands to reap major profits from the deal before he is set to leave his position as chairman after the company’s annual meeting later this year.

    Full content: Fierce Pharma

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.